Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 93

1.

Altered expression of SHIP, a Toll-like receptor pathway inhibitor, is associated with the severity of liver fibrosis in chronic hepatitis C virus infection.

Katsounas A, Trippler M, Kottilil S, Lempicki RA, Gerken G, Schlaak JF.

J Infect Dis. 2011 Oct 15;204(8):1181-5. doi: 10.1093/infdis/jir500.

PMID:
21917890
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Significance of toll-like receptors 2 and 4 mRNA expression in chronic hepatitis C virus infection.

Shehata MA, Abou El-Enein A, El-Sharnouby GA.

Egypt J Immunol. 2006;13(1):141-52.

PMID:
17974158
[PubMed - indexed for MEDLINE]
3.

CCL5 mRNA is a marker for early fibrosis in chronic hepatitis C and is regulated by interferon-α therapy and toll-like receptor 3 signalling.

Katsounas A, Trippler M, Wang B, Polis M, Lempicki RA, Kottilil S, Gerken G, Schlaak JF.

J Viral Hepat. 2012 Feb;19(2):128-37. doi: 10.1111/j.1365-2893.2011.01503.x. Epub 2011 Nov 21.

PMID:
22239502
[PubMed - indexed for MEDLINE]
4.

Intrahepatic expression of genes related to metabotropic receptors in chronic hepatitis.

Cieśla A, Kuśmider M, Faron-Górecka A, Dziedzicka-Wasylewska M, Bociąga-Jasik M, Owczarek D, Ciećko-Michalska I, Cibor D, Mach T.

World J Gastroenterol. 2012 Aug 21;18(31):4156-61. doi: 10.3748/wjg.v18.i31.4156.

PMID:
22919248
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Toll-like receptor-4 expression by hepatic progenitor cells and biliary epithelial cells in HCV-related chronic liver disease.

Vespasiani-Gentilucci U, Carotti S, Onetti-Muda A, Perrone G, Ginanni-Corradini S, Latasa MU, Avila MA, Carpino G, Picardi A, Morini S.

Mod Pathol. 2012 Apr;25(4):576-89. doi: 10.1038/modpathol.2011.197. Epub 2011 Dec 16.

PMID:
22173288
[PubMed - indexed for MEDLINE]
Free Article
6.

Insights into the pathobiology of hepatitis C virus-associated cirrhosis: analysis of intrahepatic differential gene expression.

Shackel NA, McGuinness PH, Abbott CA, Gorrell MD, McCaughan GW.

Am J Pathol. 2002 Feb;160(2):641-54.

PMID:
11839585
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Molecular profiling of early stage liver fibrosis in patients with chronic hepatitis C virus infection.

Bièche I, Asselah T, Laurendeau I, Vidaud D, Degot C, Paradis V, Bedossa P, Valla DC, Marcellin P, Vidaud M.

Virology. 2005 Feb 5;332(1):130-44.

PMID:
15661146
[PubMed - indexed for MEDLINE]
Free Article
8.

Cytokine/chemokine patterns connect host and viral characteristics with clinics during chronic hepatitis C.

Katsounas A, Trippler M, Kottilil S, Lempicki RA, Gerken G, Schlaak JF.

Eur J Med Res. 2012 May 11;17:9. doi: 10.1186/2047-783X-17-9.

PMID:
22577869
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Molecular mechanisms involved in the interaction effects of alcohol and hepatitis C virus in liver cirrhosis.

Mas VR, Fassnacht R, Archer KJ, Maluf D.

Mol Med. 2010 Jul-Aug;16(7-8):287-97. doi: 10.2119/molmed.2009.00165. Epub 2010 Mar 26.

PMID:
20386865
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

No evidence of the unfolded protein response in patients with chronic hepatitis C virus infection.

McPherson S, Powell EE, Barrie HD, Clouston AD, McGuckin M, Jonsson JR.

J Gastroenterol Hepatol. 2011 Feb;26(2):319-27. doi: 10.1111/j.1440-1746.2010.06368.x.

PMID:
21261722
[PubMed - indexed for MEDLINE]
11.

Expression and coordinated regulation of matrix metalloproteinases in chronic hepatitis C and hepatitis C virus-induced liver cirrhosis.

Lichtinghagen R, Bahr MJ, Wehmeier M, Michels D, Haberkorn CI, Arndt B, Flemming P, Manns MP, Boeker KH.

Clin Sci (Lond). 2003 Sep;105(3):373-82.

PMID:
12760742
[PubMed - indexed for MEDLINE]
Free Article
12.

Hepatic gene expression profiles associated with fibrosis progression and hepatocarcinogenesis in hepatitis C patients.

Shao RX, Hoshida Y, Otsuka M, Kato N, Tateishi R, Teratani T, Shiina S, Taniguchi H, Moriyama M, Kawabe T, Omata M.

World J Gastroenterol. 2005 Apr 7;11(13):1995-9.

PMID:
15800993
[PubMed - indexed for MEDLINE]
Free Article
13.

Differential expression of toll-like receptors 2 and 4 in patients with liver cirrhosis.

Manigold T, Böcker U, Hanck C, Gundt J, Traber P, Antoni C, Rossol S.

Eur J Gastroenterol Hepatol. 2003 Mar;15(3):275-82.

PMID:
12610323
[PubMed - indexed for MEDLINE]
14.

Effects of losartan on hepatic expression of nonphagocytic NADPH oxidase and fibrogenic genes in patients with chronic hepatitis C.

Colmenero J, Bataller R, Sancho-Bru P, Domínguez M, Moreno M, Forns X, Bruguera M, Arroyo V, Brenner DA, Ginès P.

Am J Physiol Gastrointest Liver Physiol. 2009 Oct;297(4):G726-34. doi: 10.1152/ajpgi.00162.2009. Epub 2009 Jul 23.

PMID:
19628656
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Matrix metalloproteinase (MMP)-2, MMP-7, and tissue inhibitor of metalloproteinase-1 are closely related to the fibroproliferative process in the liver during chronic hepatitis C.

Lichtinghagen R, Michels D, Haberkorn CI, Arndt B, Bahr M, Flemming P, Manns MP, Boeker KH.

J Hepatol. 2001 Feb;34(2):239-47.

PMID:
11281552
[PubMed - indexed for MEDLINE]
16.

Gene expression profiling of HCV genotype 3a initial liver fibrosis and cirrhosis patients using microarray.

Ahmad W, Ijaz B, Hassan S.

J Transl Med. 2012 Mar 7;10:41. doi: 10.1186/1479-5876-10-41.

PMID:
22397681
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Peripheral B cells may serve as a reservoir for persistent hepatitis C virus infection.

Ito M, Masumi A, Mochida K, Kukihara H, Moriishi K, Matsuura Y, Yamaguchi K, Mizuochi T.

J Innate Immun. 2010;2(6):607-17. doi: 10.1159/000317690. Epub 2010 Aug 17.

PMID:
20714117
[PubMed - indexed for MEDLINE]
18.

Tissue inhibitors of metalloproteinases in liver and serum/plasma in chronic active hepatitis C and HCV-induced cirrhosis.

Böker KH, Pehle B, Steinmetz C, Breitenstein K, Bahr M, Lichtinghagen R.

Hepatogastroenterology. 2000 May-Jun;47(33):812-9.

PMID:
10919037
[PubMed - indexed for MEDLINE]
19.

Gene expression profile associated with superimposed non-alcoholic fatty liver disease and hepatic fibrosis in patients with chronic hepatitis C.

Younossi ZM, Afendy A, Stepanova M, Hossain N, Younossi I, Ankrah K, Gramlich T, Baranova A.

Liver Int. 2009 Oct;29(9):1403-12. doi: 10.1111/j.1478-3231.2009.02060.x. Epub 2009 Jun 3.

PMID:
19515216
[PubMed - indexed for MEDLINE]
20.

Toll-like receptor expression in chronic hepatitis C: correlation with pro-inflammatory cytokine levels and liver injury.

Riordan SM, Skinner NA, Kurtovic J, Locarnini S, McIver CJ, Williams R, Visvanathan K.

Inflamm Res. 2006 Jul;55(7):279-85.

PMID:
16955390
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk